A C57BL/KsJ mouse model of Niemann-Pick disease (spm) belongs to the same complementation group as the major childhood type of Niemann-Pick disease type C

Human Genetics

Volumn 99, Issue 3, 1997, Pages 350-353

  Akaboshi, Shinjiro ^a   Yano, Tamami ^b   Miyawaki, Shigeki ^c   Ohno, Kousaku ^b   Takeshita, Kenzo ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FILIPIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CELL LINE; CLINICAL ARTICLE; ESTERIFICATION; FEMALE; FIBROBLAST; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HYBRIDIZATION; MALE; MULTINUCLEAR CELL; NIEMANN PICK DISEASE; PRIORITY JOURNAL; SOMATIC CELL;

3T3 CELLS; ADULT; ANIMALS; CELL FUSION; CELL LINE; CELL NUCLEUS; CHILD; CHOLESTEROL; CHOLESTEROL ESTERS; DISEASE MODELS, ANIMAL; FEMALE; FILIPIN; GENETIC COMPLEMENTATION TEST; HUMANS; MALE; MICE; MICE, INBRED C57BL; NIEMANN-PICK DISEASES;

EID: 0031057790     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050370     Document Type: Article

References (18)

1. Bernini F, Corsini A, Raiteri M, Soma MR, Paoletti R (1993) Effects of lacidipine on experimental models of atherosclerosis. J Hypertens Suppl 11:S61-6
2. Butler JD, Blanchette-Mackie J, Goldin E, O'Neil RR, Carstea D, Roff CF, Patterson MC, Patel S, Comly ME, Cooney A, Vanier MT, Brady RO, Pentchev PG (1992) Progesterone blocks cholesterol translocation from lysosomes. J Biol Chem 267:23797-23805
3. Carstea ED, Polymeropoulos MH, Parker CC, Detera-Wadleigh SD, O'Neil RR, Patterson MC, Goldin E, Xiao H, Straub RE, Vanier MT, Brady RO, Pentchev PG. (1993) Linkage of Niemann-Pick disease type C to human chromosome 18. Proc Natl Acad Sci USA 90:2002-2004
4. Dahl NK, Daunais MA, Liscum L (1994) A second complementation class of cholesterol transport mutants with a variant Niemann-Pick type C phenotype. J Lipid Res 35:1839-1849
5. Fink JK, Filling-Katz MR, Sokol J, Cogan DG, Pikus MA, Sonies B, Soong B, Pentchev PG, Comly ME, Brady RO, Barton NW (1989) Clinical spectrum of Niemann-Pick disease type C. Neurology 39:1040-1049
6. Furuchi T, Aikawa K, Aral H, Inoue K (1993) Bafilomycin Al, a specific inhibitor of vacuolar-type H+-ATPase, blocks lysosomal cholesterol trafficking in macrophages. J Biol Chem 268: 27345-27348
7. Kurimasa A, Ohno K, Oshimura M (1993) Restoration of the cholesterol metabolism in 3T3 cell lines derived from the sphingomyelinosis mouse (spm/spm) by transfer of a human chromosome 18. Hum Genet 92:157-162
8. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
9. Masson M, Spezzeatti B, Chapman J, Battisti C, Baumann N (1992) Calmodulin antagonists chloropromazine and W-7 inhibit exogenous cholesterol esterification and sphingomyelinase activity in human skin fibroblast cultures. Similarities between drug-induced and Niemann-Pick type C lipidoses. J Neurosci Res 31:84-88
10. Miyawaki S, Yoshida H, Mitsuoka S, Enomoto H, Ikehara S (1986) A mouse model for Niemann-Pick disease. Influence of genetic background on disease expression in spm/spm mice. J Hered 77:379-384
11. Ohno K, Nanba E, Miyazaki S, Sakiyama T, Kitagawa T, Takeshita K (1992) A cell line from sphingomyelinosis mouse shows alterations in intracellular cholesterol metabolism similar to type C Niemann-Pick disease. Cell Struct Funct 17:229-235
12. Ohno K, Nanba E, Nakano T, Inui K, Okada S, Takeshita K (1993) Altered sensitivities to potential inhibitors of cholesterol biosysthesis in Niemann-Pick type fibroblasts. Cell Struct Funct 18:231-240
13. Pentchev PG, Vanier MT, Suzuki K, Patterson MC (1995) Niemann-Pick disease type C: a cellular cholesterol lipidosis. In: Scriver SR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGrawHill, New York, pp 2625-2639
14. Steinberg SJ, Ward CP, Fensom AH (1994) Complementation studies in Niemann-Pick disease type C indicate the existence of a second group. J Med Genet 31:317-320
15. Vanier MT, Wenger DA, Comly ME, Rousson R, Brady RO, Pentchev PG (1988) Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. Clin Genet 33:331-348
16. Vanier MT, Rodriguez-Lafrasse C, Rousson R, Gazzah N, Juge MC, Pentchev PG, Revol A, Louisot P (1991a) Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim Biophys Acta 1096:328-337
17. Vanier MT, Rodriguez-Lafrasse C, Rousson R, Duthel S, Harzer K, Pentchev PG, Revol A, Louisot P (1991b) Type C Niemann-Pick disease: biochemical aspects and phenotype heterogeneity. Dev Neurosci 13:307-314
18. Vanier MT, Duthel S. Rodriguez-Lafrasse C, Pentchev P, Carstea ED (1996) Genetic heterogeneity in Niemann-Pick C disease: a study using somatic cell hybridization and linkage analysis. Am J Hum Genet 58:118-125